HCPCS Level II · October 2026
New HCPCS Level II Codes for October 2026
Effective . 44 new codes in this release.
← All changes in October 2026| Code | Description |
|---|---|
| A2046 | Dermisphere hdrt, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2047 | Lacertamatrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2048 | Puraply mz, per milligram |
| A2049 | Theracor, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2050 | Fibrillar collagen wound dressing, per milligram |
| A4228 | Supplies for maintenance of non-insulin, device-drug combination infusion catheter, per week |
| A6614 | Supplies and accessories for use with an external ocular negative pressure pump, any type, per month |
| A9613 | Piflufolastat f 18 (pylarify truvu), diagnostic, 1 millicurie |
| C9311 | Injection, eplontersen, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| C9312 | Injection, trabectedin (apotex), not therapeutically equivalent to j9362, 0.01 mg |
| C9313 | Injection, pivekimab sunirine-pvzy, 0.01 mg |
| E0788 | Ambulatory infusion pump, specific device-drug combination, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient |
| E2403 | External ocular negative pressure pump, electric |
| G0685 | Algorithm-based assessment of likelihood of autism spectrum disorder (asd), derived from validated analysis of eye-gaze data or other technology |
| J0643 | Injection, leucovorin calcium, not otherwise specified, 1 mg |
| J0644 | Injection, leucovorin calcium (avyxa), 1 mg |
| J0871 | Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg |
| J1757 | Injection, tividenofusp alfa-eknm, 1 mg |
| J1818 | Injection, pegzilarginase-nbln, 0.05 mg |
| J1946 | Injection, furosemide (lasix onyu), 1 mg |
| J1947 | Injection, furosemide (furoscix), 1 mg |
| J1957 | Injection, levetiracetam, 5 mg |
| J1958 | Injection, levetiracetam in sodium chloride, 5 mg |
| J3268 | Injection, delafloxacin, 1 mg |
| J3406 | Injection, omidubicel-onlv, per therapeutic dose |
| J7524 | Mycophenolate mofetil, oral, 5 mg |
| J7526 | Injection, mycophenolate mofetil, 5 mg |
| J7529 | Mycophenolate mofetil, for suspension, oral, 5 mg |
| J7530 | Mycophenolate mofetil (myhibbin), oral suspension, 5 mg |
| J7531 | Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg |
| J9066 | Injection, bendamustine hydrochloride (avyxa), 1 mg |
| J9186 | Injection, etoposide (avyxa), 1 mg |
| J9187 | Injection, etoposide, 1 mg |
| J9191 | Injection, fluorouracil (avyxa), 10 mg |
| J9192 | Injection, fluorouracil, 10 mg |
| J9362 | Injection, trabectedin, 0.01 mg |
| L1330 | Thoracic orthosis, sternal and/or sternocostal compression, may include anterior and/or posterior pads, panels, with or without frame, prefabricated, includes fitting and adjustment |
| L1972 | Ankle foot orthosis, plastic or other material with ankle joint, with or without dorsiflexion assist, prefabricated, off-the shelf |
| L8697 | External accessory for use with implantable phrenic nerve stimulation device, replacement, each |
| Q4207 | Carbon life, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4223 | Dermabind sl optic, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4243 | Amchomatrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q5172 | Injection, filgrastim-laha (filkri), biosimilar, 1 microgram |
| Q5173 | Injection, denosumab-adet (ponlimsi), biosimilar, 1 mg |